Cognition Therapeutics Inc (CGTX)
0.7566
-0.06
(-7.75%)
USD |
NASDAQ |
Jan 08, 12:38
Cognition Therapeutics Research and Development Expense (Annual): 37.20M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
MetaVia Inc | 9.158M |
Dermata Therapeutics Inc | 4.070M |
ZyVersa Therapeutics Inc | 3.208M |
Merck & Co Inc | 30.53B |
NovaBay Pharmaceuticals Inc | 0.068M |